NCT04959175 2026-04-09Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1/2 Recruiting320 enrolled